Home
>
ipos-financial-filings
| Revenue | $50,000,000.00 |
|---|---|
| Net Income | $22,720,000.00 |
| Total Assets | $130,386,000.00 |
| Total Liabilities | $$5,702,000.00 |
| Stockholders' Equity | ($67,936,000.00) |
| COMPANY NAME | FORM TYPE | DATE RECEIVED | VIEW |
|---|---|---|---|
| Contineum Therapeutics, Inc. | S-1 | 2024-03-15 00:00:00 | Link |
| Contineum Therapeutics, Inc. | S-1 | 2024-03-15 00:00:00 | Link |
| Contineum Therapeutics, Inc. | S-1/A | 2024-04-01 00:00:00 | Link |
| Contineum Therapeutics, Inc. | S-1 | 2024-03-15 00:00:00 | Link |
| Contineum Therapeutics, Inc. | S-1/A | 2024-04-01 00:00:00 | Link |
| Contineum Therapeutics, Inc. | 424B4 | 2024-04-08 00:00:00 | Link |
